TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 15261880

Group type: EXPERIMENTAL
Intervention: SPECT imaging using [(99m)Tc]TRODAT-1
Number of subjects: 29

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 29
Study: 11396751

Group type: COMPARATOR
Intervention: 0.25% bupivacaine 0.5 ml/kg (group B)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine 0.5 ml/kg with 50 microg/kg midazolam (group BM)
Number of subjects: 30
Study: 10029389

Group type: EXPERIMENTAL
Intervention: Passive closed drains
Number of subjects: 80

Group type: COMPARATOR
Intervention: High‐vacuum systems
Number of subjects: 80
Study: 8075014

Group type: EXPERIMENTAL
Intervention: Pictorial support (picture depicting the initial physical situation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: No pictorial support (control group not explicitly mentioned)
Number of subjects: 0
Study: 3192861

Group type: EXPERIMENTAL
Intervention: Allergen inhalation challenge
Number of subjects: 14

Group type: COMPARATOR
Intervention: Phosphate-buffered saline (control challenge)
Number of subjects: 14
Study: 29948281

Group type: EXPERIMENTAL
Intervention: GentleWave (GW) System
Number of subjects: 56

Group type: COMPARATOR
Intervention: ProUltra PiezoFlow Active Ultrasonic System (PF)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both systems (GW and PF)
Number of subjects: 56
Study: 29121999

Group type: EXPERIMENTAL
Intervention: Treatment partner and psychoeducation intervention
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Text message reminders of clinic appointments
Number of subjects: 77

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 77
Study: 26253728

Group type: EXPERIMENTAL
Intervention: sRAGE levels
Number of subjects: 3763

Group type: EXPERIMENTAL
Intervention: AGE levels
Number of subjects: 3763

Group type: EXPERIMENTAL
Intervention: sRAGE and AGE levels
Number of subjects: 3763
Study: 23129815

Group type: EXPERIMENTAL
Intervention: Motor imagery training (15 minutes of imagining normal gait movement embedded in 30 minutes of gait training, 45 minutes/day, 3 times/week)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Gait training only (30 minutes/day, 3 times/week)
Number of subjects: 28
Study: 21161652

Group type: EXPERIMENTAL
Intervention: Bursectomy
Number of subjects: 210

Group type: COMPARATOR
Intervention: Nonbursectomy
Number of subjects: 210
Study: 18458892

Group type: EXPERIMENTAL
Intervention: Efavirenz
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted atazanavir
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Ritonavir-boosted lopinavir
Number of subjects: 52
Study: 16566675

Group type: EXPERIMENTAL
Intervention: COLD-fX (200 mg/capsule, 2 capsules/day)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: COLD-fX
Number of subjects: 43
Study: 14736353

Group type: EXPERIMENTAL
Intervention: Hippotherapy (8 minutes)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Stationary sitting astride a barrel (8 minutes)
Number of subjects: 15
Study: 11571330

Group type: EXPERIMENTAL
Intervention: Transdermal nicotine patches (17.5 mg in the first week, 35.0 mg in the second and third weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo patches
Number of subjects: 32
Study: 9590313

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 75

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Propofol combined with Midazolam (Synergistic)
Number of subjects: 75
Study: 7923961

Group type: EXPERIMENTAL
Intervention: Steroids or a combination of steroids and cytotoxic therapy
Number of subjects: 17

Group type: COMPARATOR
Intervention: Untreated patients
Number of subjects: 17
Study: 3392755

Group type: EXPERIMENTAL
Intervention: Reduced Environmental Stimulation Therapy (REST) with anti-alcohol messages for 2.5 hours
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Reduced Environmental Stimulation Therapy (REST) with revised anti-alcohol message for 2.5 hours
Number of subjects: 2

Group type: COMPARATOR
Intervention: Control group (no REST)
Number of subjects: 2
Study: 30684078

Group type: EXPERIMENTAL
Intervention: Disposable endoscope (DE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional endoscopy
Number of subjects: 0
Study: 28095412

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure lowering (target SBP <125 mmHg)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Guideline blood pressure lowering (target SBP <140 mmHg)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Intensive lipid lowering (target LDL-cholesterol <1.3 mmol/l)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Guideline lipid lowering (target LDL-c <3.0 mmol/l)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Intensive lipid lowering therapy
Number of subjects: 83

Group type: COMPARATOR
Intervention: Guideline lipid lowering therapy
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure and lipid lowering
Number of subjects: 83

Group type: COMPARATOR
Intervention: Guideline blood pressure and lipid lowering
Number of subjects: 83
Study: 26765631

Group type: EXPERIMENTAL
Intervention: Motor Exercise (ME)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Cardiovascular Exercise (CE)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 71
Study: 23233551

Group type: EXPERIMENTAL
Intervention: Individualized lifestyle consultation
Number of subjects: 13016

Group type: COMPARATOR
Intervention: Control group (no individualized lifestyle consultation)
Number of subjects: 13016
Study: 21492255

Group type: EXPERIMENTAL
Intervention: 1.5 mg/kg/day of liposomal amphotericin B for 5 days
Number of subjects: 35

Group type: COMPARATOR
Intervention: 20 mgSbV/kg/day of N-methyl glucamine for 20 days
Number of subjects: 35
Study: 19531744

Group type: EXPERIMENTAL
Intervention: (99m)Tc-hydroxymethylene diphosphonate (HDP) digital blood flow scintigraphy
Number of subjects: 57
Study: 17573730

Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT) with standardized cat dander extract
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15367188

Group type: EXPERIMENTAL
Intervention: Emdogain (enamel matrix derivative) application
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control treatment (no Emdogain application)
Number of subjects: 22
Study: 11258087

Group type: EXPERIMENTAL
Intervention: Active, maxillary, flat‐plane, hard acrylic splint
Number of subjects: 63

Group type: COMPARATOR
Intervention: Palatal splint that did not interfere with occlusion
Number of subjects: 63
Study: 9568790

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol intervention
Number of subjects: 29133

Group type: COMPARATOR
Intervention: Baseline serum alpha-tocopherol, dietary vitamin E, or selenium
Number of subjects: 29133
Study: 7628832

Group type: EXPERIMENTAL
Intervention: Insulin (0.15 IU insulin/kg body weight) to induce hypoglycemia
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo (0.9% NaCl)
Number of subjects: 10
Study: 2699072

Group type: EXPERIMENTAL
Intervention: Preoperative irradiation (40 Gy) and cystectomy
Number of subjects: 107

Group type: COMPARATOR
Intervention: Radical radiation therapy (60 Gy) and salvage cystectomy
Number of subjects: 107
Study: 323663

Group type: EXPERIMENTAL
Intervention: tri-potassium di-citrato bismuthate (De-Nol)
Number of subjects: 46

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 46
Study: 31790555

Group type: EXPERIMENTAL
Intervention: ASD
Number of subjects: 1014

Group type: COMPARATOR
Intervention: Referents
Number of subjects: 1014
Study: 31676001

Group type: EXPERIMENTAL
Intervention: Home-based HIV testing and counselling (HB-HTC) during two visits (one weekday and one weekend)
Number of subjects: 18286

Group type: COMPARATOR
Intervention: First visit (weekday)
Number of subjects: 18286

Group type: EXPERIMENTAL
Intervention: Second visit (weekend)
Number of subjects: 18286

Group type: EXPERIMENTAL
Intervention: Cost per person tested
Number of subjects: 18286
Study: 28866338

Group type: EXPERIMENTAL
Intervention: Lacosamide 200mg/day
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Lacosamide 400mg/day
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study: 25879648

Group type: EXPERIMENTAL
Intervention: Freeze-thawed maternal milk (MM)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Combined fresh and freeze-thawed maternal milk (MM)
Number of subjects: 140
Study: 24331029

Group type: EXPERIMENTAL
Intervention: In utero percutaneous vesicoamniotic shunting (VAS)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 31
Study: 21304241

Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg (half-dose)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Lansoprazole 30 mg (standard-dose)
Number of subjects: 91
Study: 19562371

Group type: EXPERIMENTAL
Intervention: Physical inactivity indicators (watching television >1 hour on weekdays, club sports participation <1 time/week, sweetened drinks consumption ≥3 times/week, skipping breakfast)
Number of subjects: 1079

Group type: EXPERIMENTAL
Intervention: Maternal smoking during pregnancy, parental overweight, low parental education
Number of subjects: 1079

Group type: EXPERIMENTAL
Intervention: Migration background
Number of subjects: 1079

Group type: EXPERIMENTAL
Intervention: Lifestyle changes targeting physical inactivity and dietary habits
Number of subjects: 1079
Study: 17339618

Group type: EXPERIMENTAL
Intervention: Recombinant human parathyroid hormone (1-84)
Number of subjects: 2532

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2532
Study: 15028562

Group type: EXPERIMENTAL
Intervention: Montelukast (10 mg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (440 microg/day)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Montelukast plus Fluticasone propionate (10 mg + 440 microg/day)
Number of subjects: 12
Study: 11797986

Group type: EXPERIMENTAL
Intervention: Long sheath
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard sheath
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Long sheath (in phase 2 after standard failure)
Number of subjects: 104
Study: 9726242

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 530

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 530
Study: 9272100

Group type: EXPERIMENTAL
Intervention: Growth hormone (GH) replacement therapy (2 IU/m2)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 27
Study: 1848880

Group type: EXPERIMENTAL
Intervention: Surgical correction with crossed intrinsic transfer
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Surgical correction (method not specified)
Number of subjects: 86
Study: 6815696

Group type: EXPERIMENTAL
Intervention: 6-azamianserin (2 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: mianserin (6 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: flurazepam (10 mg)
Number of subjects: 11

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 6-azamianserin (0.5 and 1.0 mg of (+) and (‐) enantiomers)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: mianserin
Number of subjects: 11
Study: 31919289

Group type: EXPERIMENTAL
Intervention: NICU music therapy intervention, Multimodal Neurologic Enhancement
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study: 30489382

Group type: EXPERIMENTAL
Intervention: 2 mg of oral ropinirole twice daily added on to current medication
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo twice daily added on to current medication
Number of subjects: 32
Study: 28074671

Group type: EXPERIMENTAL
Intervention: Illusory kinesthesia
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 22
Study: 27137507

Group type: EXPERIMENTAL
Intervention: Primary care delivered by a nurse practitioner (n = 94)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Services-as-usual (n = 106)
Number of subjects: 200
Study: 24786357

Group type: EXPERIMENTAL
Intervention: 4Fr transradial coronary intervention
Number of subjects: 160

Group type: COMPARATOR
Intervention: 6Fr transradial coronary intervention
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 160
Study: 22283962

Group type: EXPERIMENTAL
Intervention: Eye of the needle technique
Number of subjects: 80

Group type: COMPARATOR
Intervention: Triangulation method
Number of subjects: 80
Study: 20386477

Group type: EXPERIMENTAL
Intervention: Intense plyometric exercises
Number of subjects: 24

Group type: COMPARATOR
Intervention: Rest (Control)
Number of subjects: 24
Study: 18757262

Group type: EXPERIMENTAL
Intervention: Fulvestrant loading dose regimen (500 mg on day 0, 250 mg on days 14 and 28, then 250 mg each month thereafter)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Fulvestrant loading dose regimen
Number of subjects: 37
Study: 15908119

Group type: EXPERIMENTAL
Intervention: Four different sets of auditory stimuli (1, 2, 3, or 4 frequency bands); total range: 0-2500 Hz; only the 4-band set contained intelligible words.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Most complex and most speech-like condition (4 frequency bands).
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tone-like trials (less complex conditions).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increasing number of presented frequency components.
Number of subjects: 0
Study: 12571256

Group type: EXPERIMENTAL
Intervention: Iodixanol
Number of subjects: 129

Group type: COMPARATOR
Intervention: Iohexol
Number of subjects: 129
Study: 10320237

Group type: EXPERIMENTAL
Intervention: Centrifugal pump (CFP)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Roller pump
Number of subjects: 29
Study: 9187987

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass (CPB) flow rate of 2.3 L/min/m2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass (CPB) flow rate of 1.2 L/min/m2
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Post-bypass period with persistent hemodilution
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reduced flow at 27 degrees C
Number of subjects: 30
Study: 1553603

Group type: EXPERIMENTAL
Intervention: Cefoxitin (2 grams IV every 6 hours)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Ceftizoxime (2 grams IV every 12 hours)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Cefoxitin and Ceftizoxime
Number of subjects: 81
Study: 3890463

Group type: EXPERIMENTAL
Intervention: Daily whole body soap wash and umbilical cleansing with 4% chlorhexidine detergent solution (Hibiscrub)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily whole body soap wash and umbilical cleansing with benzine solution
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Daily whole body soap wash and umbilical cleansing with 0.05% chlorhexidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Daily whole body soap wash (control group)
Number of subjects: 0
Study: 30929703

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Stress Reduction (MBSR)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Therapy for Insomnia (MBTI)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Self‐monitoring control (SM)
Number of subjects: 36
Study: 30246715

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Paliperidone
Number of subjects: 98
Study: 26561342

Group type: EXPERIMENTAL
Intervention: Intensity-modulated radiotherapy (IMRT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: 3D conformal radiotherapy (3D-RT)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Both IMRT and 3D conformal RT
Number of subjects: 59
Study: 23849907

Group type: EXPERIMENTAL
Intervention: Pre-activity of rectus femoris
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Pre-activity of lateral hamstring
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: EMG pre-activity parameters
Number of subjects: 35
Study: 22688429

Group type: EXPERIMENTAL
Intervention: Automated, interactive, tailored, telephone-based health communication intervention and tailored print materials
Number of subjects: 312

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 312
Study: 19054631

Group type: EXPERIMENTAL
Intervention: Incentives for on-time adherence (vouchers redeemable for goods)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no incentives)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention group (vouchers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intervention (vouchers)
Number of subjects: 0
Study: 17305624

Group type: EXPERIMENTAL
Intervention: Electrostimulation using a device mounted on an individualized intra‐oral removable appliance for 10 minutes.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham stimulation for 10 minutes.
Number of subjects: 0
Study: 15117900

Group type: EXPERIMENTAL
Intervention: GnRH agonist leuprolide acetate followed by recombinant human FSH (r-hFSH; 100 IU/day) and hCG (2000 IU/twice a week) for 2 months (Group A1 and B1)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Recombinant human FSH (r-hFSH) for 2 months (Group A2 and B2)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Recombinant human FSH (r-hFSH) for 2 months (Group C)
Number of subjects: 97
Study: 11250847

Group type: EXPERIMENTAL
Intervention: Late presenters (advanced glaucoma)
Number of subjects: 220
Study: 7506160

Group type: EXPERIMENTAL
Intervention: nimesulide (200mg 3 times daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: diclofenac (100mg 3 times daily)
Number of subjects: 40
Study: 3552694

Group type: EXPERIMENTAL
Intervention: Single-dose fosfomycin trometamol (3 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pipemidic acid (200-gram doses b.i.d. for 7 days)
Number of subjects: 0
Study: 29040357

Group type: EXPERIMENTAL
Intervention: Responsible drinking messages (RDM) posters in a bar laboratory (alcohol cue rich environment)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control posters in a bar laboratory (alcohol cue rich environment)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Responsible drinking messages (RDM) posters in a traditional laboratory (alcohol cue sparse environment)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control posters in a traditional laboratory (alcohol cue sparse environment)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both RDM and control posters
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Visual attention to RDMs
Number of subjects: 100
Study: 28659161

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training
Number of subjects: 22

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 22
Study: 26696453

Group type: EXPERIMENTAL
Intervention: Provisional T-stenting
Number of subjects: 202

Group type: COMPARATOR
Intervention: Routine T-stenting
Number of subjects: 202
Study: 23558093

Group type: EXPERIMENTAL
Intervention: Deleobuvir 400 mg three times daily plus faldaprevir 120 mg once daily and weight-based ribavirin for 4 weeks
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Deleobuvir 600 mg three times daily plus faldaprevir 120 mg once daily and weight-based ribavirin for 4 weeks
Number of subjects: 32
Study: 21234767

Group type: EXPERIMENTAL
Intervention: 0.125 mg/kg/min landiolol
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: 0.25 mg/kg/min landiolol
Number of subjects: 98

Group type: COMPARATOR
Intervention: Saline infusion
Number of subjects: 98
Study: 18445733

Group type: EXPERIMENTAL
Intervention: Teaching a new word (e.g. 'whisk') paired with a novel picture, repeated exposure not specified.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable, control group of typically developing peers matched on receptive language.
Number of subjects: 0
Study: 16488665

Group type: EXPERIMENTAL
Intervention: 1 min pre-wash before surgical hand disinfection
Number of subjects: 44

Group type: COMPARATOR
Intervention: No pre-wash before surgical hand disinfection
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: No pre-wash but use of a brush for 1 min during disinfection
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 15 s hand wash
Number of subjects: 44
Study: 12559216

Group type: EXPERIMENTAL
Intervention: Routine clinical follow up investigations within 6-18 months after first diagnosis of DCM (n=281)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Patients who did not present for routine follow up (n=153)
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: Deterioration of clinical status by at least one NYHA-class during follow up
Number of subjects: 480

Group type: EXPERIMENTAL
Intervention: New onset or worsening of mitral regurgitation during follow up
Number of subjects: 480
Study: 10847567

Group type: EXPERIMENTAL
Intervention: Transtibial amputation
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Transfemoral amputation
Number of subjects: 9
Study: 9354852

Group type: COMPARATOR
Intervention: Insertion/deletion (I/D) polymorphism of the angiotensin-I converting enzyme gene
Number of subjects: 247
Study: 8232927

Group type: EXPERIMENTAL
Intervention: Sensory stimulation (acupuncture) twice a week for 10 weeks
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group receiving daily physiotherapy and occupational therapy
Number of subjects: 78
Study: 2891182

Group type: EXPERIMENTAL
Intervention: Somatostatin (7.5 micrograms/min)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 30624092

Group type: EXPERIMENTAL
Intervention: OFD + L-PRF
Number of subjects: 16

Group type: COMPARATOR
Intervention: OFD
Number of subjects: 16
Study: 27241995

Group type: EXPERIMENTAL
Intervention: Bonded lingual spurs
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Conventional lingual spurs
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control group (untreated subjects)
Number of subjects: 68
Study: 26242112

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy combined with Chinese medicine (CM)
Number of subjects: 336

Group type: COMPARATOR
Intervention: Adjuvant chemotherapy
Number of subjects: 336
Study: 23235956

Group type: EXPERIMENTAL
Intervention: Arthroscopic ankle arthrodesis
Number of subjects: 60

Group type: COMPARATOR
Intervention: Open ankle arthrodesis
Number of subjects: 60
Study: 21051704

Group type: EXPERIMENTAL
Intervention: First-time trichiasis surgery
Number of subjects: 2615
Study: 19330754

Group type: EXPERIMENTAL
Intervention: Prophylactic intraoperative pneumoperitoneum
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no pneumoperitoneum)
Number of subjects: 60